companies

Sonio

Founded 2020
Employees 35+
Primary contact
24 rue du Faubourg Saint-Jacques
75014 Paris
Île-de-France
France
+33 7 88 67 07 52
Links
https://sonio.ai/en/
Sections
Technologies
Sonio has developed an AI-enabled SaaS guiding practitioners during prenatal ultrasound scans to optimize prenatal diagnosis. The company's solutions include Sonio Diagnostics, Sonio Pro, and Sonio Share. Sonio Diagnostics combines the patient's medical history, genetic and biological data, and ultrasound semiology to assist physicians on the path to the right diagnosis. Sonio Pro is made to assist sonographers during prenatal screening scans, ensuring that they have not forgotten anything and facilitating the sharing of images with patients and other health professionals. Finally, Sonio Share enables healthcare professionals to easily share ultrasound images and clips with their patients.
Select partners: Necker-Enfants Malades Hospital, Samsung Healthcare, LifeCell (India), Manager Systems (Brazil), Dynamic Medical (Nigeria), Astrimed (Portugal).
Founded 2020
Employees 35+
Primary contact
24 rue du Faubourg Saint-Jacques
75014 Paris
Île-de-France
France
+33 7 88 67 07 52
Links
https://sonio.ai/en/
Sections
Technologies

Funding 💰

Total €27.7M
Last round 🔗 $14M
Series A
July 11, 2023.
Select investors European Innovation Council, Bpifrance, Elaia, OneRagtime, Cross Border Impact Ventures

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • Solving the problem: It is reported that 50% of congenital malformations are not detected before birth, and this is what Sonio wants to address. Its software provides prenatal medicine practitioners with all types of medical, imaging, genetic and environmental data to optimize prenatal screening and diagnosis - which is a game-changer for the sector. 🔗
  • Years in the making: Sonio's technology builds upon 5 years of R&D and clinical development at Ecole Polytechnique, the PRAIRIE Institute, and Necker Hospital in Paris.
  • Clinically validated: Sonio Diagnostics is CE marked as of May 26, 2021. During the (CE marking) process, the software has managed to diagnose 294 recognizable syndromes and 688 anomalies. It also achieved an accuracy rate higher than 95% for the top 7 diagnoses produced. 🔗
  • Global ambitions: Beyond Europe, the company has found partners for its technology in India, Nigeria, Brazil and is planning to expand to the U.S. 🔗

Video ▶️

In the news 📰

France's Sonio raises $14M for its AI prenatal screening solution
July 11, 2023

Quotes 💬

“
Sonio has created an innovative platform that empowers fetal ultrasound technology, enhancing the effectiveness and efficiency of fetal medicine specialists. Additionally, it aims to bridge the increasing shortage of specialized healthcare workers worldwide. We take pride in leading this significant round of financing, as it contributes to the early growth of this venture.
— Annie Thériault, Managing Partner at Cross-Border Impact Ventures 🔗
Last update: July 18, 2023